Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Mar. 31, 2018
Dec. 31, 2017
Current assets:        
Cash $ 59,000 $ 634,000    
Prepaid expenses 212,000 83,000    
Accounts receivable 7,000 1,000    
Total current assets 278,000 718,000    
Deferred offering costs 488,000 162,000    
Property and equipment, net 7,000 11,000    
Other assets 51,000 7,000    
Total assets 824,000 898,000    
Current liabilities:        
Accounts payable and accrued expenses 2,171,000 1,148,000    
Accrued officers' salary 205,000 188,000    
Accrued interest (including $45,000 and $41,000 payable to related parties) 55,000 46,000    
Note payable, net of discount of $8,000 and $0, respectively 355,000    
Notes payable - related parties 170,000 112,000    
Convertible notes payable, net of discount of $533,000 and $1,082,000, respectively 1,867,000 818,000    
Derivative liability 2,020,000 2,576,000 $ 1,735,000 $ 1,251,000
Total current liabilities 6,843,000 4,888,000    
Long-term liabilities:        
Notes payable - related parties 1,065,000 1,065,000    
Total liabilities 7,908,000 5,953,000    
Stockholders' deficit        
Preferred stock, $0.0001 par value, 15,000,000 shares authorized, none issued or outstanding    
Common stock, $0.0001 par value, 200,000,000 shares authorized, 12,344,451 and 12,055,491 shares issued and outstanding as of March 31, 2019 and December 31, 2018 1,000 1,000    
Additional paid-in capital 36,590,000 35,611,000    
Accumulated deficit (43,675,000) (40,667,000)    
Total stockholders' deficit (7,084,000) (5,055,000) $ (2,789,000) $ (5,789,000)
Total liabilities and stockholders' deficit $ 824,000 $ 898,000